The use of tenofovir disoproxil fumarate for the treatment of nucleoside-resistant HIV-1MCCOLL, Damian J; MILLER, Michael D.Journal of antimicrobial chemotherapy (Print). 2003, Vol 51, Num 2, pp 219-223, issn 0305-7453, 5 p.Article

Strand transfer inhibitors of HIV-1 integrase: Bringing IN a new era of antiretroviral therapyMCCOLL, Damian J; XIAOWU CHEN.Antiviral research. 2010, Vol 85, Num 1, pp 101-118, issn 0166-3542, 18 p.Article

Prevalence, genotypic associations and phenotypic characterization of K65R, L74V and other HIV-1 RT resistance mutations in a commercial databaseMCCOLL, Damian J; CHAPPEY, Colombe; PARKIN, Neil T et al.Antiviral therapy (London). 2008, Vol 13, Num 2, pp 189-197, issn 1359-6535, 9 p.Article

Trends in HIV-1 reverse transcriptase resistance-associated mutations and antiretroviral prescription data from 2003-2010MILLER, Michael D; HADDAD, Mojgan; SU, Cathy et al.Antiviral therapy (London). 2012, Vol 17, Num 6, pp 993-999, issn 1359-6535, 7 p.Article

In vitro resistance selections using elvitegravir, raltegravir, and two metabolites of elvitegravir M1 and M4MARGOT, Nicolas A; HLUHANICH, Rebecca M; JONES, Gregg S et al.Antiviral research. 2012, Vol 93, Num 2, pp 288-296, issn 0166-3542, 9 p.Article

Triazole derivatives as non-nucleoside inhibitors of HIV-1 reverse transcriptase : Structure-activity relationships and crystallographic analysisKIRSCHBERG, Thorsten A; BALAKRISHNAN, Mini; WEI HUANG et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 3, pp 1131-1134, issn 0960-894X, 4 p.Article

Low level of the K103N HIV-1 above a threshold is associated with virological failure in treatment-naive individuals undergoing efavirenz-containing therapyGOODMAN, Derrick D; YUN ZHOU; MARGOT, Nicolas A et al.AIDS (London). 2011, Vol 25, Num 3, pp 325-333, issn 0269-9370, 9 p.Article

Development of HIV-1 Drug Resistance Through 144 Weeks in Antiretroviral-Naïve Subjects on Emtricitabine, Tenofovir Disoproxil Fumarate, and Efavirenz Compared With Lamivudine/Zidovudine and Efavirenz in Study GS-01-934MARGOT, Nicolas A; ENEJOSA, Jeff; CHENG, Andrew K et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 52, Num 2, pp 209-221, issn 1525-4135, 13 p.Article

Impact of Primary Elvitegravir Resistance-Associated Mutations in HIV-1 Integrase on Drug Susceptibility and Viral Replication FitnessABRAM, Michael E; HLUHANICH, Rebecca M; SVAROVSKAIA, Evguenia S et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 6, pp 2654-2663, issn 0066-4804, 10 p.Article

Patterns of resistance emerging in HIV-1 from antiretroviral-experienced patients undergoing intensification therapy with tenofovir disoproxil fumarateMCCOLL, Damian J; MARGOT, Nicolas A; WULFSOHN, Michael et al.Journal of acquired immune deficiency syndromes (1999). 2004, Vol 37, Num 3, pp 1340-1350, issn 1525-4135, 11 p.Article